+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Brachytherapy Devices Market - Global Forecast to 2030- Product Image
Brachytherapy Devices Market - Global Forecast to 2030- Product Image
Sale

Brachytherapy Devices Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011098
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Brachytherapy Devices Market grew from USD 1.41 billion in 2024 to USD 1.60 billion in 2025. It is expected to continue growing at a CAGR of 13.65%, reaching USD 3.04 billion by 2030.

Brachytherapy has emerged as a cornerstone in modern oncology, offering localized radiation treatment that maximizes tumor control while minimizing exposure to surrounding healthy tissue. Over the past decade, advances in device design, imaging integration, and treatment planning have accelerated the adoption of both high‐dose rate and low‐dose rate systems across a growing array of cancer indications. Hospitals, ambulatory surgical centers, and specialty clinics are increasingly turning to brachytherapy to deliver precise, patient‐centric care that aligns with the broader shift toward minimally invasive therapies. As regulatory bodies refine guidelines and reimbursement frameworks evolve, the competitive landscape is intensifying. Innovations in remote afterloading, seed implant technology, and digital treatment planning are redefining clinical workflows, enabling practitioners to optimize dose distributions and enhance patient outcomes. Anchored by robust clinical evidence and technological refinement, the brachytherapy devices market stands at the threshold of significant transformation. This executive summary examines the forces shaping this dynamic environment, offering insights into recent shifts, the impact of evolving trade policies, critical segmentation trends, regional growth drivers, competitive strategies, and actionable guidance for stakeholders committed to leading in the brachytherapy space.

Transformative Shifts Shaping the Brachytherapy Devices Market

The brachytherapy market is experiencing transformative shifts driven by technological breakthroughs, regulatory realignments, and evolving patient expectations. Advances in imaging modalities such as cone beam CT and MRI integration have elevated treatment precision, enabling real‐time dose verification and adaptive planning. Remote afterloading systems are increasingly favored over manual methods, reducing radiation exposure to clinical staff while enhancing workflow efficiency. Simultaneously, the emergence of seed implants with novel isotopes and biodegradable carriers is broadening the therapeutic scope. On the regulatory front, authorities in key markets have streamlined approval pathways for software‐driven treatment planning, reflecting a growing trust in digital solutions. Patient‐centric trends, including shorter treatment sessions and outpatient delivery models, are reshaping care pathways. Furthermore, the integration of artificial intelligence and machine learning into planning algorithms promises more personalized dose prescriptions based on tumor morphology and patient anatomy. These converging forces are not only refining clinical outcomes but also ushering in a new era where brachytherapy is positioned as a first‐line treatment in multiple oncology protocols.

Assessing the Cumulative Impact of United States 2025 Tariffs on Brachytherapy

The introduction of new 2025 tariffs on imported medical devices in the United States has added complexity to supply‐chain dynamics and cost structures across the brachytherapy ecosystem. Device manufacturers reliant on components sourced abroad face increased production expenses, which may be passed on to end users in the form of higher procurement prices. Treatment planning software providers and isotope suppliers are also navigating altered pricing agreements, forcing contract renegotiations and logistical adjustments. For health systems operating on tight budgets, the cumulative effect of these tariffs could slow capital investments in next‐generation afterloading platforms and imaging‐integrated suites. In response, several stakeholders are accelerating domestic manufacturing initiatives, forming strategic alliances with U.S.‐based suppliers, and leveraging scale economies to mitigate cost pressures. While these measures promise greater supply‐chain resilience, they require upfront capital and long‐term planning. As tariffs reshape vendor selection and purchasing cycles, market participants must adopt agile sourcing strategies to maintain access to cutting‐edge brachytherapy solutions without compromising financial sustainability.

Key Segmentation Insights Across Types, Applications, End Users and Techniques

A nuanced understanding of market dynamics emerges when brachytherapy adoption is examined across device type, clinical application, end‐user segment, and treatment technique. From a device standpoint, the sector divides into high‐dose rate systems-where both manual and remote afterloading technologies play a critical role-and low‐dose rate offerings, which encompass permanent seed implants as well as temporary brachytherapy applications. In clinical practice, practitioners employ brachytherapy to treat breast cancer using accelerated partial breast irradiation or intraoperative radiation therapy, gynecological malignancies including cervical and endometrial cancers, and prostate cancer where boost therapy and monotherapy approaches are common. End users extend from high‐volume hospitals, both private and public, to ambulatory surgical centers and specialty clinics such as oncology practices and radiotherapy centers. Treatment techniques are similarly diverse, spanning interstitial methods-whether permanent or temporary-alongside intracavitary approaches in endobronchial or vaginal placements, and intraluminal procedures targeting luminal structures. By mapping performance metrics and adoption rates across these intersecting dimensions, stakeholders can pinpoint underserved segments and tailor product development, training initiatives, and marketing strategies to address specific clinical needs.

Regional Dynamics Driving Growth in Americas, EMEA, and Asia-Pacific

Regional markets exhibit distinct growth trajectories driven by infrastructure maturity, reimbursement frameworks, and oncology burden. In the Americas, robust healthcare spending and favorable reimbursement for advanced radiation therapies underpin steady uptake of next‐generation brachytherapy platforms. Stakeholders benefit from established distribution networks and a high volume of prostate and gynecological cancer treatments. Europe, the Middle East & Africa present a heterogeneous landscape where advanced economies in Western Europe adopt cutting‐edge afterloading systems while emerging markets in the Middle East invest in oncology centers to expand access. Regulatory harmonization efforts and public‐private partnerships are pivotal to sustaining growth. In Asia‐Pacific, rapid expansion of hospital infrastructure in China, India, and Southeast Asia, coupled with growing cancer incidence, is fueling demand for both low‐dose rate seed technologies and high‐dose rate remote afterloading. Strategic collaborations, local manufacturing, and targeted training programs are accelerating market penetration across the region.

Competitive Landscape Insights: Leading Brachytherapy Device Manufacturers

The competitive landscape is defined by a mixture of established medical device conglomerates, specialized oncology technology innovators, and emerging niche players. Becton, Dickinson and Company and Boston Scientific Corporation maintain broad portfolios spanning imaging, afterloading systems, and treatment planning software. Siemens Healthineers AG, General Electric Company, and Carl Zeiss AG leverage their strengths in imaging integration to deliver seamless guidance solutions. Elekta AB and Varian Medical Systems Inc. continue to refine remote afterloading technologies, while CivaTech Oncology and C4 Imaging LLC differentiate through novel isotope formulations and advanced digital dosimetry tools. Niche specialists such as iCAD, Inc., IsoAid, LLC, and Theragenics Corporation focus on seed implant innovations, whereas Qfix, Sun Nuclear Corporation, and Hologic Inc. optimize applicators and quality assurance instruments. Emerging companies like Dexur Inc., SeeDOS Ltd., and Panacea Medical Technologies Pvt. Ltd. are forging strategic partnerships with research institutions to validate new techniques. This dynamic interplay of scale, specialization, and innovation is driving rapid iteration in product design, clinical support services, and software functionality.

Actionable Recommendations for Industry Leaders to Navigate Market Complexity

To thrive amid evolving market dynamics, industry leaders should prioritize strategic investments in digital workflow integration, ensuring seamless interoperability between treatment planning software, imaging systems, and afterloading platforms. Diversifying supply chains by establishing partnerships with domestic component manufacturers can mitigate tariff‐related cost pressures and safeguard production continuity. Collaboration with academic and clinical research centers accelerates clinical validation of novel isotopes, applicators, and AI‐driven planning algorithms, strengthening product differentiation. Providers should tailor value‐based pricing models to reflect outcome improvements and reduced total cost of care, engaging payers and health systems in shared‐savings agreements. Finally, robust training programs for oncologists, physicists, and radiation therapists will facilitate the adoption of advanced techniques, driving volume growth and improving patient satisfaction.

Conclusion: Positioning for Success in the Brachytherapy Market

The brachytherapy devices market is poised for sustained growth as technological innovation, patient‐centric care models, and strategic realignments reshape clinical practice. Advanced imaging integration and AI‐enhanced planning tools are set to become standard components of comprehensive treatment suites, while shifts toward outpatient delivery models will broaden access. Tariff‐driven supply‐chain adjustments and regional investment patterns demand agile strategies that balance cost management with clinical excellence. By leveraging segmentation insights and partnering across the value chain, manufacturers and care providers can unlock new opportunities in both mature and emerging markets. As the competitive landscape intensifies, the companies that successfully harmonize innovation, operational resilience, and stakeholder collaboration will define the next generation of brachytherapy solutions.

Market Segmentation & Coverage

This research report categorizes the Brachytherapy Devices Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • High-Dose Rate (HDR)
    • Manual Afterloading
    • Remote Afterloading
  • Low-Dose Rate (LDR)
    • Permanent Seed Implants
    • Temporary Brachytherapy
  • Breast Cancer
    • Accelerated Partial Breast Irradiation (APBI)
    • Intraoperative Radiation Therapy (IORT)
  • Gynecological Cancer
    • Cervical Cancer
    • Endometrial Cancer
  • Prostate Cancer
    • Boost Therapy
    • Monotherapy
  • Ambulatory Surgical Centers
  • Hospitals
    • Private Hospitals
    • Public Hospitals
  • Specialty Clinics
    • Oncology Clinics
    • Radiotherapy Centers
  • Interstitial
    • Permanent
    • Temporary
  • Intracavitary
    • Endobronchial
    • Vaginal
  • Intraluminal

This research report categorizes the Brachytherapy Devices Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Brachytherapy Devices Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Becton, Dickinson and Company
  • Biobot Surgical Pte Ltd.
  • Boston Scientific Corporation
  • C4 Imaging LLC
  • Carl Zeiss AG
  • CivaTech Oncology
  • Dexur Inc.
  • Eckert & Ziegler BEBIG S.A.
  • Elekta AB
  • General Electric Company
  • Guangzhou Perception Vision Medical Technologies Co.,Ltd.
  • Hologic Inc.
  • iCAD, Inc.
  • IsoAid, LLC
  • Merit Medical Systems, Inc.
  • Mick Radio-Nuclear Instruments Inc.
  • Panacea Medical Technologies Pvt. Ltd.
  • Perspective Therapeutics
  • Qfix
  • SeeDOS Ltd.
  • Siemens Healthineers AG
  • Sun Nuclear Corporation
  • Theragenics Corporation
  • Valco Instruments Company Incorporated
  • Varian Medical Systems Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Brachytherapy Devices Market, by Type
8.1. Introduction
8.2. High-Dose Rate (HDR)
8.2.1. Manual Afterloading
8.2.2. Remote Afterloading
8.3. Low-Dose Rate (LDR)
8.3.1. Permanent Seed Implants
8.3.2. Temporary Brachytherapy
9. Brachytherapy Devices Market, by Application
9.1. Introduction
9.2. Breast Cancer
9.2.1. Accelerated Partial Breast Irradiation (APBI)
9.2.2. Intraoperative Radiation Therapy (IORT)
9.3. Gynecological Cancer
9.3.1. Cervical Cancer
9.3.2. Endometrial Cancer
9.4. Prostate Cancer
9.4.1. Boost Therapy
9.4.2. Monotherapy
10. Brachytherapy Devices Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.3.1. Private Hospitals
10.3.2. Public Hospitals
10.4. Specialty Clinics
10.4.1. Oncology Clinics
10.4.2. Radiotherapy Centers
11. Brachytherapy Devices Market, by Technique
11.1. Introduction
11.2. Interstitial
11.2.1. Permanent
11.2.2. Temporary
11.3. Intracavitary
11.3.1. Endobronchial
11.3.2. Vaginal
11.4. Intraluminal
12. Americas Brachytherapy Devices Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Brachytherapy Devices Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Brachytherapy Devices Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Becton, Dickinson and Company
15.3.2. Biobot Surgical Pte Ltd.
15.3.3. Boston Scientific Corporation
15.3.4. C4 Imaging LLC
15.3.5. Carl Zeiss AG
15.3.6. CivaTech Oncology
15.3.7. Dexur Inc.
15.3.8. Eckert & Ziegler BEBIG S.A.
15.3.9. Elekta AB
15.3.10. General Electric Company
15.3.11. Guangzhou Perception Vision Medical Technologies Co.,Ltd.
15.3.12. Hologic Inc.
15.3.13. iCAD, Inc.
15.3.14. IsoAid, LLC
15.3.15. Merit Medical Systems, Inc.
15.3.16. Mick Radio-Nuclear Instruments Inc.
15.3.17. Panacea Medical Technologies Pvt. Ltd.
15.3.18. Perspective Therapeutics
15.3.19. Qfix
15.3.20. SeeDOS Ltd.
15.3.21. Siemens Healthineers AG
15.3.22. Sun Nuclear Corporation
15.3.23. Theragenics Corporation
15.3.24. Valco Instruments Company Incorporated
15.3.25. Varian Medical Systems Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BRACHYTHERAPY DEVICES MARKET MULTI-CURRENCY
FIGURE 2. BRACHYTHERAPY DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. BRACHYTHERAPY DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY TECHNIQUE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BRACHYTHERAPY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BRACHYTHERAPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BRACHYTHERAPY DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH-DOSE RATE (HDR), BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY MANUAL AFTERLOADING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY REMOTE AFTERLOADING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH-DOSE RATE (HDR), 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW-DOSE RATE (LDR), BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PERMANENT SEED IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY TEMPORARY BRACHYTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW-DOSE RATE (LDR), 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY ACCELERATED PARTIAL BREAST IRRADIATION (APBI), BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY INTRAOPERATIVE RADIATION THERAPY (IORT), BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY GYNECOLOGICAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY ENDOMETRIAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY BOOST THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY MONOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY RADIOTHERAPY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY INTERSTITIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PERMANENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY TEMPORARY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY INTERSTITIAL, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY INTRACAVITARY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY ENDOBRONCHIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY VAGINAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY INTRACAVITARY, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY INTRALUMINAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH-DOSE RATE (HDR), 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW-DOSE RATE (LDR), 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY INTERSTITIAL, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY INTRACAVITARY, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA BRACHYTHERAPY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH-DOSE RATE (HDR), 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW-DOSE RATE (LDR), 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA BRACHYTHERAPY DEVICES MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA BRACHYTHERAPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA BRACHYTHERAPY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA BRACHYTHERAPY DEVICES MARKET SIZE, BY INTERSTITIAL, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA BRACHYTHERAPY DEVICES MARKET SIZE, BY INTRACAVITARY, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH-DOSE RATE (HDR), 2018-2030 (USD MILLION)
TABLE 77. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW-DOSE RATE (LDR), 2018-2030 (USD MILLION)
TABLE 78. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY INTERSTITIAL, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY INTRACAVITARY, 2018-2030 (USD MILLION)
TABLE 88. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH-DOSE RATE (HDR), 2018-2030 (USD MILLION)
TABLE 90. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW-DOSE RATE (LDR), 2018-2030 (USD MILLION)
TABLE 91. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 93. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
TABLE 94. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
TABLE 95. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 97. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 98. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 99. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY INTERSTITIAL, 2018-2030 (USD MILLION)
TABLE 100. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY INTRACAVITARY, 2018-2030 (USD MILLION)
TABLE 101. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH-DOSE RATE (HDR), 2018-2030 (USD MILLION)
TABLE 103. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW-DOSE RATE (LDR), 2018-2030 (USD MILLION)
TABLE 104. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 106. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
TABLE 107. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
TABLE 108. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 110. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 111. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 112. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY INTERSTITIAL, 2018-2030 (USD MILLION)
TABLE 113. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY INTRACAVITARY, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH-DOSE RATE (HDR), 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW-DOSE RATE (LDR), 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY INTERSTITIAL, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY INTRACAVITARY, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 128. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH-DOSE RATE (HDR), 2018-2030 (USD MILLION)
TABLE 130. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW-DOSE RATE (LDR), 2018-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
TABLE 134. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY INTERSTITIAL, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY INTRACAVITARY, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 142. AUSTRALIA BRACHYTHERAPY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. AUSTRALIA BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH-DOSE RATE (HDR), 2018-2030 (USD MILLION)
TABLE 144. AUSTRALIA BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW-DOSE RATE (LDR), 2018-2030 (USD MILLION)
TABLE 145. AUSTRALIA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. AUSTRALIA BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 147. AUSTRALIA BRACHYTHERAPY DEVICES MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
TABLE 148. AUSTRALIA BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
TABLE 149. AUSTRALIA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. AUSTRALIA BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 151. AUSTRALIA BRACHYTHERAPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 152. AUSTRALIA BRACHYTHERAPY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 153. AUSTRALIA BRACHYTHERAPY DEVICES MARKET SIZE, BY INTERSTITIAL, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA BRACHYTHERAPY DEVICES MARKET SIZE, BY INTRACAVITARY, 2018-2030 (USD MILLION)
TABLE 155. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH-DOSE RATE (HDR), 2018-2030 (USD MILLION)
TABLE 157. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW-DOSE RATE (LDR), 2018-2030 (USD MILLION)
TABLE 158. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 160. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
TABLE 161. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
TABLE 162. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 164. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 165. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 166. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY INTERSTITIAL, 2018-2030 (USD MILLION)
TABLE 167. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY INTRACAVITARY, 2018-2030 (USD MILLION)
TABLE 168. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH-DOSE RATE (HDR), 2018-2030 (USD MILLION)
TABLE 170. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW-DOSE RATE (LDR), 2018-2030 (USD MILLION)
TABLE 171. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 173. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
TABLE 174. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
TABLE 175. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 177. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 178. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 179. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY INTERSTITIAL, 2018-2030 (USD MILLION)
TABLE 180. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY INTRACAVITARY, 2018-2030 (USD MILLION)
TABLE 181. INDONESIA BRACHYTHERAPY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 182. INDONESIA BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH-DOSE RATE (HDR), 2018-2030 (USD MILLION)
TABLE 183. INDONESIA BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW-DOSE RATE (LDR), 2018-2030 (USD MILLION)
TABLE 184. INDONESIA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. INDONESIA BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 186. INDONESIA BRACHYTHERAPY DEVICES MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
TABLE 187. INDONESIA BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
TABLE 188. INDONESIA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. INDONESIA BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 190. INDONESIA BRACHYTHERAPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 191. INDONESIA BRACHYTHERAPY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 192. INDONESIA BRACHYTHERAPY DEVICES MARKET SIZE, BY INTERSTITIAL, 2018-2030 (USD MILLION)
TABLE 193. INDONESIA BRACHYTHERAPY DEVICES MARKET SIZE, BY INTRACAVITARY, 2018-2030 (USD MILLION)
TABLE 194. JAPAN BRACHYTHERAPY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 195. JAPAN BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH-DOSE RATE (HDR), 2018-2030 (USD MILLION)
TABLE 196. JAPAN BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW-DOSE RATE (LDR), 2018-2030 (USD MILLION)
TABLE 197. JAPAN BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. JAPAN BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 199. JAPAN BRACHYTHERAPY DEVICES MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
TABLE 200. JAPAN BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
TABLE 201. JAPAN BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. JAPAN BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 203. JAPAN BRACHYTHERAPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 204. JAPAN BRACHYTHERAPY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 205. JAPAN BRACHYTHERAPY DEVICES MARKET SIZE, BY INTERSTITIAL, 2018-2030 (USD MILLION)
TABLE 206. JAPAN BRACHYTHERAPY DEVICES MARKET SIZE, BY INTRACAVITARY, 2018-2030 (USD MILLION)
TABLE 207. MALAYSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 208. MALAYSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH-DOSE RATE (HDR), 2018-2030 (USD MILLION)
TABLE 209. MALAYSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW-DOSE RATE (LDR), 2018-2030 (USD MILLION)
TABLE 210. MALAYSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. MALAYSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 212. MALAYSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
TABLE 213. MALAYSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. MALAYSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY INTERSTITIAL, 2018-2030 (USD MILLION)
TABLE 219. MALAYSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY INTRACAVITARY, 2018-2030 (USD MILLION)
TABLE 220. PHILIPPINES BRACHYTHERAPY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 221. PHILIPPINES BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH-DOSE RATE (HDR), 2018-2030 (USD MILLION)
TABLE 222. PHILIPPINES BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW-DOSE RATE (LDR), 2018-2030 (USD MILLION)
TABLE 223. PHILIPPINES BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. PHILIPPINES BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 225. PHILIPPINES BRACHYTHERAPY DEVICES MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
TABLE 226. PHILIPPINES BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
TABLE 227. PHILIPPINES BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. PHILIPPINES BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 229. PHILIPPINES BRACHYTHERAPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 230. PHILIPPINES BRACHYTHERAPY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 231. PHILIPPINES BRACHYTHERAPY DEVICES MARKET SIZE, BY INTERSTITIAL, 2018-2030 (USD MILLION)
TABLE 232. PHILIPPINES BRACHYTHERAPY DEVICES MARKET SIZE, BY INTRACAVITARY, 2018-2030 (USD MILLION)
TABLE 233. SINGAPORE BRACHYTHERAPY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 234. SINGAPORE BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH-DOSE RATE (HDR), 2018-2030 (USD MILLION)
TABLE 235. SINGAPORE BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW-DOSE RATE (LDR), 2018-2030 (USD MILLION)
TABLE 236. SINGAPORE BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. SINGAPORE BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 238. SINGAPORE BRACHYTHERAPY DEVICES MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
TABLE 239. SINGAPORE BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
TABLE 240. SINGAPORE BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. SINGAPORE BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 242. SINGAPORE BRACHYTHERAPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 243. SINGAPORE BRACHYTHERAPY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 244. SINGAPORE BRACHYTHERAPY DEVICES MARKET SIZE, BY INTERSTITIAL, 2018-2030 (USD MILLION)
TABLE 245. SINGAPORE BRACHYTHERAPY DEVICES MARKET SIZE, BY INTRACAVITARY, 2018-2030 (USD MILLION)
TABLE 246. SOUTH KOREA BRACHYTHERAPY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 247. SOUTH KOREA BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH-DOSE RATE (HDR), 2018-2030 (USD MILLION)
TABLE 248. SOUTH KOREA BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW-DOSE RATE (LDR), 2018-2030 (USD MILLION)
TABLE 249. SOUTH KOREA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. SOUTH KOREA BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 251. SOUTH KOREA BRACHYTHERAPY DEVICES MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
TABLE 252. SOUTH KOREA BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
TABLE 253. SOUTH KOREA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. SOUTH KOREA BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 255. SOUTH KOREA BRACHYTHERAPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 256. SOUTH KOREA BRACHYTHERAPY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 257. SOUTH KOREA BRACHYTHERAPY DEVICES MARKET SIZE, BY INTERSTITIAL, 2018-2030 (USD MILLION)
TABLE 258. SOUTH KOREA BRACHYTHERAPY DEVICES MARKET SIZE, BY INTRACAVITARY, 2018-2030 (USD MILLION)
TABLE 259. TAIWAN BRACHYTHERAPY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 260. TAIWAN BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH-DOSE RATE (HDR), 2018-2030 (USD MILLION)
TABLE 261. TAIWAN BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW-DOSE RATE (LDR), 2018-2030 (USD MILLION)
TABLE 262. TAIWAN BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. TAIWAN BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 264. TAIWAN BRACHYTHERAPY DEVICES MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
TABLE 265. TAIWAN BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
TABLE 266. TAIWAN BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. TAIWAN BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 268. TAIWAN BRACHYTHERAPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 269. TAIWAN BRACHYTHERAPY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 270. TAIWAN BRACHYTHERAPY DEVICES MARKET SIZE, BY INTERSTITIAL, 2018-2030 (USD MILLION)
TABLE 271. TAIWAN BRACHYTHERAPY DEVICES MARKET SIZE, BY INTRACAVITARY, 2018-2030 (USD MILLION)
TABLE 272. THAILAND BRACHYTHERAPY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 273. THAILAND BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH-DOSE RATE (HDR), 2018-2030 (USD MILLION)
TABLE 274. THAILAND BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW-DOSE RATE (LDR), 2018-2030 (USD MILLION)
TABLE 275. THAILAND BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. THAILAND BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 277. THAILAND BRACHYTHERAPY DEVICES MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
TABLE 278. THAILAND BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
TABLE 279. THAILAND BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. THAILAND BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 281. THAILAND BRACHYTHERAPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 282. THAILAND BRACHYTHERAPY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 283. THAILAND BRACHYTHERAPY DEVICES MARKET SIZE, BY INTERSTITIAL, 2018-2030 (USD MILLION)
TABLE 284. THAILAND BRACHYTHERAPY DEVICES MARKET SIZE, BY INTRACAVITARY, 2018-2030 (USD MILLION)
TABLE 285. VIETNAM BRACHYTHERAPY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 286. VIETNAM BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH-DOSE RATE (HDR), 2018-2030 (USD MILLION)
TABLE 287. VIETNAM BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW-DOSE RATE (LDR), 2018-2030 (USD MILLION)
TABLE 288. VIETNAM BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. VIETNAM BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 290. VIETNAM BRACHYTHERAPY DEVICES MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
TABLE 291. VIETNAM BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
TABLE 292. VIETNAM BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. VIETNAM BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 294. VIETNAM BRACHYTHERAPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 295. VIETNAM BRACHYTHERAPY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 296. VIETNAM BRACHYTHERAPY DEVICES MARKET SIZE, BY INTERSTITIAL, 2018-2030 (USD MILLION)
TABLE 297. VIETNAM BRACHYTHERAPY DEVICES MARKET SIZE, BY INTRACAVITARY, 2018-2030 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH-DOSE RATE (HDR), 2018-2030 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW-DOSE RATE (LDR), 2018-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY INTERSTITIAL, 2018-2030 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY INTRACAVITARY, 2018-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 312. DENMARK BRACHYTHERAPY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 313. DENMARK BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH-DOSE RATE (HDR), 2018-2030 (USD MILLION)
TABLE 314. DENMARK BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW-DOSE RATE (LDR), 2018-2030 (USD MILLION)
TABLE 315. DENMARK BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 316. DENMARK BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 317. DENMARK BRACHYTHERAPY DEVICES MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
TABLE 318. DENMARK BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
TABLE 319. DENMARK BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. DENMARK BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 321. DENMARK BRACHYTHERAPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 322. DENMARK BRACHYTHERAPY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 323. DENMARK BRACHYTHERAPY DEVICES MARKET SIZE, BY INTERSTITIAL, 2018-2030 (USD MILLION)
TABLE 324. DENMARK BRACHYTHERAPY DEVICES MARKET SIZE, BY INTRACAVITARY, 2018-2030 (USD MILLION)
TABLE 325. EGYPT BRACHYTHERAPY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 326. EGYPT BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH-DOSE RATE (HDR), 2018-2030 (USD MILLION)
TABLE 327. EGYPT BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW-DOSE RATE (LDR), 2018-2030 (USD MILLION)
TABLE 328. EGYPT BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 329. EGYPT BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 330. EGYPT BRACHYTHERAPY DEVICES MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
TABLE 331. EGYPT BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
TABLE 332. EGYPT BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 333. EGYPT BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 334. EGYPT BRACHYTHERAPY DEVICES MARKET SIZE, BY

Companies Mentioned

  • Becton, Dickinson and Company
  • Biobot Surgical Pte Ltd.
  • Boston Scientific Corporation
  • C4 Imaging LLC
  • Carl Zeiss AG
  • CivaTech Oncology
  • Dexur Inc.
  • Eckert & Ziegler BEBIG S.A.
  • Elekta AB
  • General Electric Company
  • Guangzhou Perception Vision Medical Technologies Co.,Ltd.
  • Hologic Inc.
  • iCAD, Inc.
  • IsoAid, LLC
  • Merit Medical Systems, Inc.
  • Mick Radio-Nuclear Instruments Inc.
  • Panacea Medical Technologies Pvt. Ltd.
  • Perspective Therapeutics
  • Qfix
  • SeeDOS Ltd.
  • Siemens Healthineers AG
  • Sun Nuclear Corporation
  • Theragenics Corporation
  • Valco Instruments Company Incorporated
  • Varian Medical Systems Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Brachytherapy Treatment Planning System Market - Global Forecast to 2030 - Product Image

Brachytherapy Treatment Planning System Market - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
Breast Cancer Brachytherapy Market Size, Share & Trends Analysis Report By Technology (HDR, LDR), By Product (Applicators And Afterloaders, Electronic Brachytherapy), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Breast Cancer Brachytherapy Market Size, Share & Trends Analysis Report By Technology (HDR, LDR), By Product (Applicators And Afterloaders, Electronic Brachytherapy), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Radiotherapy Market by Technology (EBRT:MR LINAC, Stereotactic, Particle; IBRT/Brachytherapy, Cobalt-60 Teletherapy), Procedure (IGRT, IMRT, 3D-CRT, HDR, LDR, PDR), Cancer (Prostate, Breast, Lung, CRC), End User (Hospital, IRC) - Global Forecasts to 2030 - Product Image

Radiotherapy Market by Technology (EBRT:MR LINAC, Stereotactic, Particle; IBRT/Brachytherapy, Cobalt-60 Teletherapy), Procedure (IGRT, IMRT, 3D-CRT, HDR, LDR, PDR), Cancer (Prostate, Breast, Lung, CRC), End User (Hospital, IRC) - Global Forecasts to 2030

  • Report
  • 313 Pages
  • Global
From
Breast Cancer Brachytherapy Market by Technology, by Product, by End-User, and By Region - Product Image

Breast Cancer Brachytherapy Market by Technology, by Product, by End-User, and By Region

  • Report
  • 200 Pages
  • Global
From

About the Brachytherapy Device Market

Brachytherapy is a type of radiation therapy used to treat cancer. It involves the placement of radioactive sources directly into or near a tumor. Brachytherapy devices are used to deliver radiation to the tumor, while minimizing exposure to surrounding healthy tissue. These devices are typically used to treat cancers of the prostate, breast, head and neck, and gynecological organs. Brachytherapy devices are typically classified into two categories: high-dose rate (HDR) and low-dose rate (LDR). HDR devices are used to deliver a high dose of radiation in a short period of time, while LDR devices are used to deliver a lower dose of radiation over a longer period of time. Both types of devices are used to treat a variety of cancers. The brachytherapy device market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Varian Medical Systems, Elekta AB, C. R. Bard, Inc., IsoRay Medical, Inc., and Eckert & Ziegler BEBIG. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.